An Improved Syngeneic Orthotopic Murine Model of
Human Breast Cancer Progression Breast Cancer Research and Treatment 2014 Oct; 147 (3): 501 - 12.
We have established a technique to generate syngeneic murine metastatic breast cancer model that mimic
human breast cancer progression (Rashid OM et al, Breast Cancer Research and Treatment 2014).
Not exact matches
Robert D. Schreiber, Ph.D., an associate director of CRI's Scientific Advisory Council based at Washington University School of Medicine in Saint Louis, Missouri, developed a new model of
breast cancer that more closely resembles the
progression of hormone receptor - positive disease in
humans, overcoming a major obstacle in the study of
breast cancer and the development of new immune - based therapies for the disease.
Mitochondrial folate transport by SLC25A32 is yet unstudied for its contribution to oncogenesis, despite knowledge that the slc25a32 gene is amplified in
human cancers (including > 40 % of
breast cancers) and this amplification is associated with accelerated disease
progression and death.
Veterinary oncologists working with a program at the University of Pennsylvania are treating mammary tumors in shelter dogs with the hope of learning about the
progression of
breast cancer in
humans.